サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1530936

前立腺治療市場：世界の産業分析、規模、シェア、成長、動向、2024～2034年予測

Prostate Health Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2024-2034

出版日
ページ情報
英文 213 Pages
納期
2～10営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.82円
前立腺治療市場：世界の産業分析、規模、シェア、成長、動向、2024～2034年予測
出版日: 2024年06月13日
発行: Transparency Market Research
ページ情報: 英文 213 Pages
納期: 2～10営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

前立腺治療市場-調査範囲

TMRの調査レポート「前立腺治療の世界市場」は、2024～2034年までの予測期間における市場の指標に関する貴重な洞察を得るために、過去だけでなく現在の成長動向と機会についても調査しています。当レポートでは、2024年を基準年、2034年を予測年として、2018～2034年までの世界の前立腺治療市場の収益と予測を提供しています。また、2024～2034年までの世界の前立腺治療市場の複合年間成長率（CAGR %）も掲載しています。

本レポートは広範な調査を経て作成されています。1次調査では、アナリストが主要オピニオンリーダー、業界リーダー、オピニオンメーカーへのインタビューを実施しました。2次調査では、主要企業の製品資料、アニュアルレポート、プレスリリース、関連資料などを参照し、前立腺治療市場を推察しました。

市場スナップショット
2023年の市場規模 3,190万米ドル
2034年の市場規模 838億米ドル
CAGR 9.2%

当レポートでは、世界の前立腺治療市場の競合情勢について調査しています。世界の前立腺治療市場で事業を展開する主要企業が特定され、各企業が様々な属性でプロファイルされています。企業概要、財務状況、最近の動向、SWOTなどが、本レポートで紹介されている世界の前立腺治療市場における参入企業の属性です。

目次

第1章 序文

第2章 前提条件と調査手法

第3章 エグゼクティブサマリー：世界市場

第4章 市場概要

  • イントロダクション
  • 概要
  • 市場力学
  • 世界の市場分析と予測、2020～2034年

第5章 主要洞察

  • 地域別/世界規模の規制シナリオ
  • 主要な業界イベント（製品の発売、コラボレーションとパートナーシップ、買収、承認など）
  • パイプライン分析
  • 主要国別の償還シナリオ
  • 前立腺疾患（前立腺炎、前立腺肥大症、前立腺がんなど）の診断
  • ブランド分析
  • 価格分析
  • COVID-19による産業への影響

第6章 世界の市場分析と予測：疾患別

  • イントロダクションと定義
  • 主要調査結果・発展
  • 市場金額予測：疾患別、2020～2034年
    • 前立腺炎
    • 良性前立腺肥大症（BPH）
    • 前立腺がん
      • 腺がん
      • 移行上皮がん
      • 扁平上皮がん
      • 小細胞前立腺がん
  • 市場の魅力分析：疾患別

第7章 世界の市場分析と予測：治療別

  • イントロダクションと定義
  • 主要調査結果・発展
  • 市場金額予測：治療別、2020～2034年
    • 化学療法
    • ホルモン療法
    • 免疫療法
  • 市場の魅力分析：治療別

第8章 世界の市場分析と予測：投与経路別

  • イントロダクションと定義
  • 主要調査結果・発展
  • 市場金額予測：投与経路別、2020～2034年
    • 経口
    • 非経口
  • 市場の魅力分析：投与経路別

第9章 世界の市場分析と予測：流通チャネル別

  • イントロダクションと定義
  • 主要調査結果・発展
  • 市場金額予測：流通チャネル別、2020～2034年
    • 病院薬局
    • 小売薬局
    • オンライン薬局
  • 市場の魅力分析：流通チャネル別

第10章 世界の市場分析と予測：地域別

  • 主要調査結果
  • 市場金額予測：地域別、2020～2034年
    • 北米
    • 欧州
    • アジア太平洋
    • ラテンアメリカ
    • 中東・アフリカ
  • 地域別の市場の魅力

第11章 北米の市場分析と予測

第12章 欧州の市場分析と予測

第13章 アジア太平洋の市場分析と予測

第14章 ラテンアメリカの市場分析と予測

第15章 中東・アフリカの市場分析と予測

第16章 競合情勢

  • 市場企業-競合マトリックス（企業階層と規模別）
  • 市場シェア分析企業別（2023年）
  • 企業プロファイル
    • Abbott Laboratories
    • Amgen Inc.
    • Astellas Pharma Inc.
    • AstraZeneca PLC
    • Bayer AG
    • Bristol-Myers Squibb（BMS）
    • Eli Lilly and Company
    • Ferring Pharmaceuticals
    • GSK PLC.
    • Johnson & Johnson
    • Merck and Co. Inc.
    • Pfizer Inc.
    • Siemens Healthineers AG
図表

List of Tables

  • Table 01: Global Prostate Health Market Value (US$ Mn) Forecast, by Disease Type, 2020-2034
  • Table 02: Global Prostate Health Market Value (US$ Mn) Forecast, by Prostate cancer, 2020-2034
  • Table 03: Global Prostate Health Market Value (US$ Mn) Forecast, by Treatment, 2020-2034
  • Table 04: Global Prostate Health Market Value (US$ Mn) Forecast, by Distribution Channel, 2020-2034
  • Table 05: Global Prostate Health Market Value (US$ Mn) Forecast, by Region, 2020-2034
  • Table 06: North America Prostate Health Market Value (US$ Mn) Forecast, by Country, 2020-2034
  • Table 07: North America Prostate Health Market Value (US$ Mn) Forecast, by Disease Type, 2020-2034
  • Table 08: North America Prostate Health Market Value (US$ Mn) Forecast, by Prostate Cancer, 2020-2034
  • Table 09: North America Prostate Health Market Value (US$ Mn) Forecast, by Treatment, 2020-2034
  • Table 10: North America Prostate Health Market Value (US$ Mn) Forecast, by Distribution Channel, 2020-2034
  • Table 11: Europe Prostate Health Market Value (US$ Mn) Forecast, by Country/Sub-region, 2020-2034
  • Table 12: Europe Prostate Health Market Value (US$ Mn) Forecast, by Disease Type, 2020-2034
  • Table 13: Europe Prostate Health Market Value (US$ Mn) Forecast, by Prostate Cancer, 2020-2034
  • Table 14: Europe Prostate Health Market Value (US$ Mn) Forecast, by Treatment, 2020-2034
  • Table 15: Europe Prostate Health Market Value (US$ Mn) Forecast, by Distribution Channel, 2020-2034
  • Table 16: Asia Pacific Prostate Health Market Value (US$ Mn) Forecast, by Country/Sub-region, 2020-2034
  • Table 17: Asia Pacific Prostate Health Market Value (US$ Mn) Forecast, by Disease Type, 2020-2034
  • Table 18: Asia Pacific Prostate Health Market Value (US$ Mn) Forecast, by Prostate Cancer, 2020-2034
  • Table 19: Asia Pacific Prostate Health Market Value (US$ Mn) Forecast, by Treatment, 2020-2034
  • Table 20: Asia Pacific Prostate Health Market Value (US$ Mn) Forecast, by Distribution Channel, 2020-2034
  • Table 21: Latin America Prostate Health Market Value (US$ Mn) Forecast, by Country/Sub-region, 2020-2034
  • Table 22: Latin America Prostate Health Market Value (US$ Mn) Forecast, by Disease Type, 2020-2034
  • Table 23: Latin America Prostate Health Market Value (US$ Mn) Forecast, by Prostate Cancer, 2020-2034
  • Table 24: Latin America Prostate Health Market Value (US$ Mn) Forecast, by Treatment, 2020-2034
  • Table 25: Latin America Prostate Health Market Value (US$ Mn) Forecast, by Distribution Channel, 2020-2034
  • Table 26: Middle East & Africa Prostate Health Market Value (US$ Mn) Forecast, by Country/Sub-region, 2020-2034
  • Table 27: Middle East & Africa Prostate Health Market Value (US$ Mn) Forecast, by Disease Type, 2020-2034
  • Table 28: Middle East & Africa Prostate Health Market Value (US$ Mn) Forecast, by Prostate Cancer, 2020-2034
  • Table 29: Middle East & Africa Prostate Health Market Value (US$ Mn) Forecast, by Treatment, 2020-2034
  • Table 30: Middle East & Africa Prostate Health Market Value (US$ Mn) Forecast, by Distribution Channel, 2020-2034

List of Figures

  • Figure 01: Global Prostate Health Market Value (US$ Mn) Forecast, 2020-2034
  • Figure 02: Global Prostate Health Market Value Share, by Disease Type, 2023
  • Figure 03: Global Prostate Health Market Value Share, by Treatment, 2023
  • Figure 04: Global Prostate Health Market Value Share, by Route of Administration, 2023
  • Figure 05: Global Prostate Health Market Value Share, by Distribution Channel, 2023
  • Figure 06: Global Prostate Health Market Value Share, by Region, 2023
  • Figure 07: Global Prostate Health Market Value (US$ Mn) Share Analysis, by Disease Type, 2023 and 2034
  • Figure 08: Global Prostate Health Market Share Analysis, by Disease Type, 2023
  • Figure 09: Global Prostate Health Market Share Analysis, by Disease Type, 2034
  • Figure 10: Global Prostate Health Market Attractiveness Analysis, by Disease Type, 2024-2034
  • Figure 11: Global Prostate Health Market Value (US$ Mn), by Prostatitis, 2020-2034
  • Figure 12: Global Prostate Health Market Value Share Analysis, by Prostatitis, 2023 and 2034
  • Figure 13: Global Prostate Health Market Value (US$ Mn), by Benign prostatic hyperplasia (BPH), 2020-2034
  • Figure 14: Global Prostate Health Market Value Share Analysis, by Benign prostatic hyperplasia (BPH), 2023 and 2034
  • Figure 15: Global Prostate Health Market Value (US$ Mn), by Prostate cancer, 2020-2034
  • Figure 16: Global Prostate Health Market Value Share Analysis, by Prostate cancer, 2023 and 2034
  • Figure 17: Global Prostate Health Market Value (US$ Mn) Share Analysis, by Treatment, 2023 and 2034
  • Figure 18: Global Prostate Health Market Share Analysis, by Treatment, 2023
  • Figure 19: Global Prostate Health Market Share Analysis, by Treatment, 2034
  • Figure 20: Global Prostate Health Market Attractiveness Analysis, by Treatment, 2024-2034
  • Figure 21: Global Prostate Health Market Value (US$ Mn), by Chemotherapy, 2020-2034
  • Figure 22: Global Prostate Health Market Value Share Analysis, by Chemotherapy, 2023 and 2034
  • Figure 23: Global Prostate Health Market Value (US$ Mn), by Hormone Therapy, 2020-2034
  • Figure 24: Global Prostate Health Market Value Share Analysis, by Hormone Therapy, 2023 and 2034
  • Figure 25: Global Prostate Health Market Value (US$ Mn), by Immunotherapy, 2020-2034
  • Figure 26: Global Prostate Health Market Value Share Analysis, by Immunotherapy, 2023 and 2034
  • Figure 27: Global Prostate Health Market Value (US$ Mn) Share Analysis, by Distribution Channel, 2023 and 2034
  • Figure 28: Global Prostate Health Market Share Analysis, by Distribution Channel, 2023
  • Figure 29: Global Prostate Health Market Share Analysis, by Distribution Channel, 2034
  • Figure 30: Global Prostate Health Market Attractiveness Analysis, by Distribution Channel, 2024-2034
  • Figure 31: Global Prostate Health Market Value (US$ Mn), by Hospital Pharmacies, 2020-2034
  • Figure 32: Global Prostate Health Market Value Share Analysis, by Hospital Pharmacies, 2023 and 2034
  • Figure 33: Global Prostate Health Market Value (US$ Mn), by Retail Pharmacies, 2020-2034
  • Figure 34: Global Prostate Health Market Value Share Analysis, by Retail Pharmacies, 2023 and 2034
  • Figure 35: Global Prostate Health Market Value (US$ Mn), by Online Pharmacies, 2020-2034
  • Figure 36: Global Prostate Health Market Value Share Analysis, by Online Pharmacies, 2023 and 2034
  • Figure 37: Global Prostate Health Market Value Share Analysis, by Region, 2023 and 2034
  • Figure 38: Global Prostate Health Market Share Analysis, by Region, 2023
  • Figure 39: Global Prostate Health Market Share Analysis, by Region, 2034
  • Figure 40: Global Prostate Health Market Attractiveness Analysis, by Region, 2024-2034
  • Figure 41: North America Prostate Health Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2020-2034
  • Figure 42: North America Prostate Health Market Value Share Analysis, by Country, 2023 and 2034
  • Figure 43: North America Prostate Health Market Attractiveness Analysis, by Country, 2024-2034
  • Figure 44: North America Prostate Health Market Value (US$ Mn) Share Analysis, by Disease Type, 2023 and 2034
  • Figure 45: North America Prostate Health Market Attractiveness Analysis, by Disease Type, 2024-2034
  • Figure 46: North America Prostate Health Market Value (US$ Mn) Share Analysis, by Treatment, 2023 and 2034
  • Figure 47: North America Prostate Health Market Attractiveness Analysis, by Treatment, 2024-2034
  • Figure 48: North America Prostate Health Market Value (US$ Mn) Share Analysis, by Distribution Channel, 2023 and 2034
  • Figure 49: North America Prostate Health Market Attractiveness Analysis, by Distribution Channel, 2024-2034
  • Figure 50: Europe Prostate Health Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2020-2034
  • Figure 51: Europe Prostate Health Market Value Share Analysis, by Country/Sub-region, 2023 and 2034
  • Figure 52: Europe Prostate Health Market Attractiveness Analysis, by Country/Sub-region, 2024-2034
  • Figure 53: Europe Prostate Health Market Value (US$ Mn) Share Analysis, by Disease Type, 2023 and 2034
  • Figure 54: Europe Prostate Health Market Attractiveness Analysis, by Disease Type, 2024-2034
  • Figure 55: Europe Prostate Health Market Value (US$ Mn) Share Analysis, by Treatment, 2023 and 2034
  • Figure 56: Europe Prostate Health Market Attractiveness Analysis, by Treatment, 2024-2034
  • Figure 57: Europe Prostate Health Market Value (US$ Mn) Share Analysis, by Distribution Channel, 2023 and 2034
  • Figure 58: Europe Prostate Health Market Attractiveness Analysis, by Distribution Channel, 2024-2034
  • Figure 59: Asia Pacific Prostate Health Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2020-2034
  • Figure 60: Asia Pacific Prostate Health Market Value Share Analysis, by Country/Sub-region, 2023 and 2034
  • Figure 61: Asia Pacific Prostate Health Market Attractiveness Analysis, by Country/Sub-region, 2024-2034
  • Figure 62: Asia Pacific Prostate Health Market Value (US$ Mn) Share Analysis, by Disease Type, 2023 and 2034
  • Figure 63: Asia Pacific Prostate Health Market Attractiveness Analysis, by Disease Type, 2024-2034
  • Figure 64: Asia Pacific Prostate Health Market Value (US$ Mn) Share Analysis, by Treatment, 2023 and 2034
  • Figure 65: Asia Pacific Prostate Health Market Attractiveness Analysis, by Treatment, 2024-2034
  • Figure 66: Asia Pacific Prostate Health Market Value (US$ Mn) Share Analysis, by Distribution Channel, 2023 and 2034
  • Figure 67: Asia Pacific Prostate Health Market Attractiveness Analysis, by Distribution Channel, 2024-2034
  • Figure 68: Latin America Prostate Health Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2020-2034
  • Figure 69: Latin America Prostate Health Market Value Share Analysis, by Country/Sub-region, 2023 and 2034
  • Figure 70: Latin America Prostate Health Market Attractiveness Analysis, by Country/Sub-region, 2024-2034
  • Figure 71: Latin America Prostate Health Market Value (US$ Mn) Share Analysis, by Disease Type, 2023 and 2034
  • Figure 72: Latin America Prostate Health Market Attractiveness Analysis, by Disease Type, 2024-2034
  • Figure 73: Latin America Prostate Health Market Value (US$ Mn) Share Analysis, by Treatment, 2023 and 2034
  • Figure 74: Latin America Prostate Health Market Attractiveness Analysis, by Treatment, 2024-2034
  • Figure 75: Latin America Prostate Health Market Value (US$ Mn) Share Analysis, by Distribution Channel, 2023 and 2034
  • Figure 76: Latin America Prostate Health Market Attractiveness Analysis, by Distribution Channel, 2024-2034
  • Figure 77: Middle East & Africa Prostate Health Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2020-2034
  • Figure 78: Middle East & Africa Prostate Health Market Value Share Analysis, by Country/Sub-region, 2023 and 2034
  • Figure 79: Middle East & Africa Prostate Health Market Attractiveness Analysis, by Country/Sub-region, 2024-2034
  • Figure 80: Middle East & Africa Prostate Health Market Value (US$ Mn) Share Analysis, by Disease Type, 2023 and 2034
  • Figure 81: Middle East & Africa Prostate Health Market Attractiveness Analysis, by Disease Type, 2024-2034
  • Figure 82: Middle East & Africa Prostate Health Market Value (US$ Mn) Share Analysis, by Treatment, 2023 and 2034
  • Figure 83: Middle East & Africa Prostate Health Market Attractiveness Analysis, by Treatment, 2024-2034
  • Figure 84: Middle East & Africa Prostate Health Market Value (US$ Mn) Share Analysis, by Distribution Channel, 2023 and 2034
  • Figure 85: Middle East & Africa Prostate Health Market Attractiveness Analysis, by Distribution Channel, 2024-2034
目次
Product Code: TMRGL84727

Prostate Health Market - Scope of Report

TMR's report on the global prostate health market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2024 to 2034. The report provides revenue of the global prostate health market for the period 2018-2034, considering 2024 as the base year and 2034 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global prostate health market from 2024 to 2034.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players' product literature, annual reports, press releases, and relevant documents to understand the prostate health market.

Market Snapshot
Market Value in 2023US$ 31.9 Mn
Market Value in 2034US$ 83.8 Bn
CAGR9.2%

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global prostate health market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the global prostate health market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global prostate health market.

The report delves into the competitive landscape of the global prostate health market. Key players operating in the global prostate health market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global prostate health market profiled in this report.

Key Questions Answered in Global prostate health Market Report:

  • What is the sales/revenue generated by prostate health across all regions during the forecast period?
  • What are the opportunities in the global prostate health market?
  • What are the major drivers, restraints, opportunities, and threats in the market?
  • Which regional market is set to expand at the fastest CAGR during the forecast period?
  • Which segment is expected to generate the highest revenue globally in 2034?
  • Which segment is projected to expand at the highest CAGR during the forecast period?
  • What are the market positions of different companies operating in the global market?

Prostate Health Market - Research Objectives and Research Approach

The comprehensive report on the global prostate health market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.

The report analyzes the global prostate health market in terms of product, end-user, and region. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2034 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global prostate health market.

Table of Contents

1. Preface

  • 1.1. Market Definition and Scope
  • 1.2. Market Segmentation
  • 1.3. Key Research Objectives
  • 1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Prostate Health Market

4. Market Overview

  • 4.1. Introduction
    • 4.1.1. Segment Definition
  • 4.2. Overview
  • 4.3. Market Dynamics
    • 4.3.1. Drivers
    • 4.3.2. Restraints
    • 4.3.3. Opportunities
  • 4.4. Global Prostate Health Market Analysis and Forecast, 2020-2034
    • 4.4.1. Market Revenue Projections (US$ Mn)

5. Key Insights

  • 5.1. Regulatory Scenario by region/globally
  • 5.2. Key Industry Events (Product Launches, Collaborations and Partnerships, Acquisitions, Approvals etc.)
  • 5.3. Pipeline Analysis
  • 5.4. Reimbursement Scenario by Key Countries
  • 5.5. Disease Diagnosis of Prostate Diseases (Prostatitis, Benign Prostate Hyperplasia, Prostate Cancer, etc.)
  • 5.6. Brand Analysis
  • 5.7. Pricing Analysis
  • 5.8. Covid-19 Pandemic Impact on Industry

6. Global Prostate Health Market Analysis and Forecast, by Disease Type

  • 6.1. Introduction & Definition
  • 6.2. Key Findings/Developments
  • 6.3. Market Value Forecast, by Disease Type, 2020-2034
    • 6.3.1. Prostatitis
    • 6.3.2. Benign Prostatic Hyperplasia (BPH)
    • 6.3.3. Prostate Cancer
      • 6.3.3.1. Adenocarcinoma
      • 6.3.3.2. Transitional Cell Carcinoma
      • 6.3.3.3. Squamous Cell Carcinoma
      • 6.3.3.4. Small Cell Prostate Cancer
  • 6.4. Market Attractiveness Analysis, by Disease Type

7. Global Prostate Health Market Analysis and Forecast, by Treatment

  • 7.1. Introduction & Definition
  • 7.2. Key Findings/Developments
  • 7.3. Market Value Forecast, by Treatment, 2020-2034
    • 7.3.1. Chemotherapy
    • 7.3.2. Hormone Therapy
    • 7.3.3. Immunotherapy
  • 7.4. Market Attractiveness Analysis, by Treatment

8. Global Prostate Health Market Analysis and Forecast, by Route of Administration

  • 8.1. Introduction & Definition
  • 8.2. Key Findings/Developments
  • 8.3. Market Value Forecast, by Route of Administration, 2020-2034
    • 8.3.1. Oral
    • 8.3.2. Parenteral
  • 8.4. Market Attractiveness Analysis, by Route of Administration

9. Global Prostate Health Market Analysis and Forecast, by Distribution Channel

  • 9.1. Introduction & Definition
  • 9.2. Key Findings/Developments
  • 9.3. Market Value Forecast, by Distribution Channel, 2020-2034
    • 9.3.1. Hospital Pharmacies
    • 9.3.2. Retail Pharmacies
    • 9.3.3. Online Pharmacies
  • 9.4. Market Attractiveness Analysis, by Distribution Channel

10. Global Prostate Health Market Analysis and Forecast, by Region

  • 10.1. Key Findings
  • 10.2. Market Value Forecast, by Region, 2020-2034
    • 10.2.1. North America
    • 10.2.2. Europe
    • 10.2.3. Asia Pacific
    • 10.2.4. Latin America
    • 10.2.5. Middle East & Africa
  • 10.3. Market Attractiveness By Region

11. North America Prostate Health Market Analysis and Forecast

  • 11.1. Introduction
    • 11.1.1. Key Findings
  • 11.2. Market Value Forecast, by Disease Type, 2020-2034
    • 11.2.1. Prostatitis
    • 11.2.2. Benign Prostatic Hyperplasia (BPH)
    • 11.2.3. Prostate Cancer
      • 11.2.3.1. Adenocarcinoma
      • 11.2.3.2. Transitional Cell Carcinoma
      • 11.2.3.3. Squamous Cell Carcinoma
      • 11.2.3.4. Small Cell Prostate Cancer
  • 11.3. Market Value Forecast, by Treatment, 2020-2034
    • 11.3.1. Chemotherapy
    • 11.3.2. Hormone Therapy
    • 11.3.3. Immunotherapy
  • 11.4. Market Value Forecast, by Route of Administration, 2020-2034
    • 11.4.1. Oral
    • 11.4.2. Parenteral
  • 11.5. Market Value Forecast, by Distribution Channel, 2020-2034
    • 11.5.1. Hospital Pharmacies
    • 11.5.2. Retail Pharmacies
    • 11.5.3. Online Pharmacies
  • 11.6. Market Value Forecast, by Country
    • 11.6.1. U.S.
    • 11.6.2. Canada
  • 11.7. Market Attractiveness Analysis
    • 11.7.1. By Disease Type
    • 11.7.2. By Treatment
    • 11.7.3. By Route of Administration
    • 11.7.4. By Distribution Channel
    • 11.7.5. By Country

12. Europe Prostate Health Market Analysis and Forecast

  • 12.1. Introduction
    • 12.1.1. Key Findings
  • 12.2. Market Value Forecast, by Disease Type, 2020-2034
    • 12.2.1. Prostatitis
    • 12.2.2. Benign Prostatic Hyperplasia (BPH)
    • 12.2.3. Prostate Cancer
      • 12.2.3.1. Adenocarcinoma
      • 12.2.3.2. Transitional Cell Carcinoma
      • 12.2.3.3. Squamous Cell Carcinoma
      • 12.2.3.4. Small Cell Prostate Cancer
  • 12.3. Market Value Forecast, by Treatment, 2020-2034
    • 12.3.1. Chemotherapy
    • 12.3.2. Hormone Therapy
    • 12.3.3. Immunotherapy
  • 12.4. Market Value Forecast, by Route of Administration, 2020-2034
    • 12.4.1. Oral
    • 12.4.2. Parenteral
  • 12.5. Market Value Forecast, by Distribution Channel, 2020-2034
    • 12.5.1. Hospital Pharmacies
    • 12.5.2. Retail Pharmacies
    • 12.5.3. Online Pharmacies
  • 12.6. Market Value Forecast, by Country/Sub-region, 2020-2034
    • 12.6.1. Germany
    • 12.6.2. UK
    • 12.6.3. France
    • 12.6.4. Italy
    • 12.6.5. Spain
    • 12.6.6. Rest of Europe
  • 12.7. Market Attractiveness Analysis
    • 12.7.1. By Disease Type
    • 12.7.2. By Treatment
    • 12.7.3. By Route of Administration
    • 12.7.4. By Distribution Channel
    • 12.7.5. By Country/Sub-region

13. Asia Pacific Prostate Health Market Analysis and Forecast

  • 13.1. Introduction
    • 13.1.1. Key Findings
  • 13.2. Market Value Forecast, by Disease Type, 2020-2034
    • 13.2.1. Prostatitis
    • 13.2.2. Benign prostatic hyperplasia (BPH)
    • 13.2.3. Prostate Cancer
      • 13.2.3.1. Adenocarcinoma
      • 13.2.3.2. Transitional Cell Carcinoma
      • 13.2.3.3. Squamous Cell Carcinoma
      • 13.2.3.4. Small Cell Prostate Cancer
  • 13.3. Market Value Forecast, by Treatment, 2020-2034
    • 13.3.1. Chemotherapy
    • 13.3.2. Hormone Therapy
    • 13.3.3. Immunotherapy
  • 13.4. Market Value Forecast, by Route of Administration, 2020-2034
    • 13.4.1. Oral
    • 13.4.2. Parenteral
  • 13.5. Market Value Forecast, by Distribution Channel, 2020-2034
    • 13.5.1. Hospital Pharmacies
    • 13.5.2. Retail Pharmacies
    • 13.5.3. Online Pharmacies
  • 13.6. Market Value Forecast, by Country/Sub-region, 2020-2034
    • 13.6.1. China
    • 13.6.2. Japan
    • 13.6.3. India
    • 13.6.4. Australia & New Zealand
    • 13.6.5. Rest of Asia Pacific
  • 13.7. Market Attractiveness Analysis
    • 13.7.1. By Disease Type
    • 13.7.2. By Treatment
    • 13.7.3. By Route of Administration
    • 13.7.4. By Distribution Channel
    • 13.7.5. By Country/Sub-region

14. Latin America Prostate Health Market Analysis and Forecast

  • 14.1. Introduction
    • 14.1.1. Key Findings
  • 14.2. Market Value Forecast, by Disease Type, 2020-2034
    • 14.2.1. Prostatitis
    • 14.2.2. Benign prostatic hyperplasia (BPH)
    • 14.2.3. Prostate Cancer
      • 14.2.3.1. Adenocarcinoma
      • 14.2.3.2. Transitional Cell Carcinoma
      • 14.2.3.3. Squamous Cell Carcinoma
      • 14.2.3.4. Small Cell Prostate Cancer
  • 14.3. Market Value Forecast, by Treatment, 2020-2034
    • 14.3.1. Chemotherapy
    • 14.3.2. Hormone Therapy
    • 14.3.3. Immunotherapy
  • 14.4. Market Value Forecast, by Route of Administration, 2020-2034
    • 14.4.1. Oral
    • 14.4.2. Parenteral
  • 14.5. Market Value Forecast, by Distribution Channel, 2020-2034
    • 14.5.1. Hospital Pharmacies
    • 14.5.2. Retail Pharmacies
    • 14.5.3. Online Pharmacies
  • 14.6. Market Value Forecast, by Country/Sub-region, 2020-2034
    • 14.6.1. Brazil
    • 14.6.2. Mexico
    • 14.6.3. Rest of Latin America
  • 14.7. Market Attractiveness Analysis
    • 14.7.1. By Disease Type
    • 14.7.2. By Treatment
    • 14.7.3. By Route of Administration
    • 14.7.4. By Distribution Channel
    • 14.7.5. By Country/Sub-region

15. Middle East & Africa Prostate Health Market Analysis and Forecast

  • 15.1. Introduction
    • 15.1.1. Key Findings
  • 15.2. Market Value Forecast, by Disease Type, 2020-2034
    • 15.2.1. Prostatitis
    • 15.2.2. Benign prostatic hyperplasia (BPH)
    • 15.2.3. Prostate Cancer
      • 15.2.3.1. Adenocarcinoma
      • 15.2.3.2. Transitional Cell Carcinoma
      • 15.2.3.3. Squamous Cell Carcinoma
      • 15.2.3.4. Small Cell Prostate Cancer
  • 15.3. Market Value Forecast, by Treatment, 2020-2034
    • 15.3.1. Chemotherapy
    • 15.3.2. Hormone Therapy
    • 15.3.3. Immunotherapy
  • 15.4. Market Value Forecast, by Route of Administration, 2020-2034
    • 15.4.1. Oral
    • 15.4.2. Parenteral
  • 15.5. Market Value Forecast, by Distribution Channel, 2020-2034
    • 15.5.1. Hospital Pharmacies
    • 15.5.2. Retail Pharmacies
    • 15.5.3. Online Pharmacies
  • 15.6. Market Value Forecast, by Country/Sub-region, 2020-2034
    • 15.6.1. GCC Countries
    • 15.6.2. South Africa
    • 15.6.3. Rest of Middle East & Africa
  • 15.7. Market Attractiveness Analysis
    • 15.7.1. By Disease Type
    • 15.7.2. By Treatment
    • 15.7.3. By Route of Administration
    • 15.7.4. By Distribution Channel
    • 15.7.5. By Country/Sub-region

16. Competition Landscape

  • 16.1. Market Player - Competition Matrix (By Tier and Size of companies)
  • 16.2. Market Share Analysis By Company (2023)
  • 16.3. Company Profiles
    • 16.3.1. Abbott Laboratories
      • 16.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.1.2. Product Portfolio
      • 16.3.1.3. Financial Overview
      • 16.3.1.4. SWOT Analysis
      • 16.3.1.5. Strategic Overview
    • 16.3.2. Amgen Inc.
      • 16.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.2.2. Product Portfolio
      • 16.3.2.3. Financial Overview
      • 16.3.2.4. SWOT Analysis
      • 16.3.2.5. Strategic Overview
    • 16.3.3. Astellas Pharma Inc.
      • 16.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.3.2. Product Portfolio
      • 16.3.3.3. Financial Overview
      • 16.3.3.4. SWOT Analysis
      • 16.3.3.5. Strategic Overview
    • 16.3.4. AstraZeneca PLC
      • 16.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.4.2. Product Portfolio
      • 16.3.4.3. Financial Overview
      • 16.3.4.4. SWOT Analysis
      • 16.3.4.5. Strategic Overview
    • 16.3.5. Bayer AG
      • 16.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.5.2. Product Portfolio
      • 16.3.5.3. Financial Overview
      • 16.3.5.4. SWOT Analysis
      • 16.3.5.5. Strategic Overview
    • 16.3.6. Bristol-Myers Squibb (BMS)
      • 16.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.6.2. Product Portfolio
      • 16.3.6.3. Financial Overview
      • 16.3.6.4. SWOT Analysis
      • 16.3.6.5. Strategic Overview
    • 16.3.7. Eli Lilly and Company
      • 16.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.7.2. Product Portfolio
      • 16.3.7.3. Financial Overview
      • 16.3.7.4. SWOT Analysis
      • 16.3.7.5. Strategic Overview
    • 16.3.8. Ferring Pharmaceuticals
      • 16.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.8.2. Product Portfolio
      • 16.3.8.3. Financial Overview
      • 16.3.8.4. SWOT Analysis
      • 16.3.8.5. Strategic Overview
    • 16.3.9. GSK PLC.
      • 16.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.9.2. Product Portfolio
      • 16.3.9.3. Financial Overview
      • 16.3.9.4. SWOT Analysis
      • 16.3.9.5. Strategic Overview
    • 16.3.10. Johnson & Johnson
      • 16.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.10.2. Product Portfolio
      • 16.3.10.3. Financial Overview
      • 16.3.10.4. SWOT Analysis
      • 16.3.10.5. Strategic Overview
    • 16.3.11. Merck and Co. Inc.
      • 16.3.11.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.11.2. Product Portfolio
      • 16.3.11.3. Financial Overview
      • 16.3.11.4. SWOT Analysis
      • 16.3.11.5. Strategic Overview
    • 16.3.12. Pfizer Inc.
      • 16.3.12.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.12.2. Product Portfolio
      • 16.3.12.3. Financial Overview
      • 16.3.12.4. SWOT Analysis
      • 16.3.12.5. Strategic Overview
    • 16.3.13. Siemens Healthineers AG
      • 16.3.13.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.13.2. Product Portfolio
      • 16.3.13.3. Financial Overview
      • 16.3.13.4. SWOT Analysis
      • 16.3.13.5. Strategic Overview